atropine has been researched along with chloramphenicol in 49 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (chloramphenicol) | Trials (chloramphenicol) | Recent Studies (post-2010) (chloramphenicol) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 20,113 | 388 | 1,464 |
Protein | Taxonomy | atropine (IC50) | chloramphenicol (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.43 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (57.14) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (26.53) | 29.6817 |
2010's | 8 (16.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Beech, J | 1 |
Baker, CJ; Sastry, RV | 1 |
Gayda, RC; Henderson, GW; Markovitz, A | 1 |
Guilbert, F; Malbrel, PH | 1 |
Erb, HN; Neaderland, MH; Rebhun, WC; Riis, RC | 1 |
Jensen, AD; Naidoff, MA | 1 |
Ganshorn, A; Kurz, H | 1 |
Eustace, P; Pierse, D | 1 |
Dohlman, CH; McCulley, JP; Sullivan, WR | 1 |
Brown, TC | 1 |
Hvidberg-Hansen, J; Kleener, J; Larsen, FE | 1 |
Bracegirdle, JR; Perry, BD | 1 |
Ellis, PP | 1 |
Gorski, RA; Shryne, J | 1 |
Körner, H | 1 |
Costello, JM; Shannon, FT | 1 |
Honegger, H | 1 |
Dugmore, W | 1 |
Bergaust, B; Westby, RK | 1 |
Luchik, VI; Radzikhovskiĭ, BL | 1 |
Dev, S; Jain, IS | 1 |
Knecht, CD; Schiller, AG; Small, E | 1 |
Aguilar, R; Bowersox, S; Chávez, L; Dreyfus-Cortés, G; Drucker-Colín, R; McGinty, D | 1 |
GILLESPIE, FD | 1 |
ANTONI, AA; BROWN, A | 1 |
RICHARDS, AG | 1 |
BIRKS, DA | 1 |
Imran, D; Lewis, D | 1 |
3 review(s) available for atropine and chloramphenicol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Principles of therapy.
Topics: Adrenal Cortex Hormones; Aerosols; Ampicillin; Animals; Atropine; Bronchodilator Agents; Chloramphenicol; Cromolyn Sodium; Horse Diseases; Horses; Isoniazid; Oxytetracycline; Penicillins; Pyrilamine; Respiratory Tract Diseases | 1979 |
Systemic reactions to topical therapy.
Topics: Adult; Aged; Atropine; Carbachol; Child, Preschool; Chloramphenicol; Cholinesterase Inhibitors; Cocaine; Epinephrine; Glucocorticoids; Humans; Isoproterenol; Male; Ophthalmic Solutions; Parasympatholytics; Parasympathomimetics; Phenylephrine; Pilocarpine; Scopolamine; Tropanes | 1971 |
46 other study(ies) available for atropine and chloramphenicol
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Endophthalmitis associated with Haemophilus influenzae type b bacteremia and meningitis.
Topics: Administration, Topical; Ampicillin; Atropine; Chloramphenicol; Cyclopentolate; Dexamethasone; Endophthalmitis; Female; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Injections, Intravenous; Male; Meningitis, Haemophilus; Microbial Sensitivity Tests; Neomycin; Ophthalmic Solutions; Phenylephrine; Polymyxin B; Prednisone; Scopolamine; Sepsis | 1979 |
Neuroactive drugs inhibit trypsin and outer membrane protein processing in Escherichia coli K-12.
Topics: Anesthetics, Local; Atropine; Bacterial Proteins; Chloramphenicol; Escherichia coli; Membrane Fluidity; Membrane Proteins; Plasmids; Procaine; Protein Precursors; Temperature; Trypsin; Trypsin Inhibitors | 1979 |
[Treatment of a case of severe ulcer of the cornea, using Medi-Flow].
Topics: Adult; Ascorbic Acid; Atropine; Chloramphenicol; Corneal Ulcer; Female; Humans; Sodium Chloride | 1976 |
Healing of experimentally induced corneal ulcers in horses.
Topics: Animals; Atropine; Chloramphenicol; Corneal Ulcer; Female; Horse Diseases; Horses; Male; Ointments; Phenylbutazone; Time Factors | 1987 |
Drugs in breast milk.
Topics: Anticoagulants; Anticonvulsants; Antineoplastic Agents; Antithyroid Agents; Aspirin; Atropine; Caffeine; Chloramphenicol; Chlorothiazide; Contraceptives, Oral; Ergot Alkaloids; Ethanol; Female; Humans; Hypnotics and Sedatives; Methadone; Milk, Human; Nalidixic Acid; Narcotics; Penicillins; Quinine; Reserpine; Sulfonamides; Tetracycline | 1974 |
Bilateral meningococcal endophthalmitis.
Topics: Atropine; Borates; Child; Chloramphenicol; Conjunctiva; Cornea; Endophthalmitis; Exudates and Transudates; Female; Glaucoma; Hemorrhage; Humans; Meningococcal Infections; Neisseria meningitidis; Ophthalmoscopy; Penicillin G; Prednisone; Sepsis | 1973 |
[Differences between the protein binding of newborns and adults and their importance for pharmacological action].
Topics: Acetaminophen; Age Factors; Aminosalicylic Acids; Atropine; Chloramphenicol; Humans; Infant, Newborn; Isoniazid; Methicillin; Morphine; Nitrofurantoin; Oxyphenbutazone; Phenacetin; Phenobarbital; Phenytoin; Promethazine; Protein Binding; Salicylates; Sulfadimethoxine; Thiopental | 1968 |
Acute keratoconus in mongols.
Topics: Acute Disease; Adolescent; Adult; Atropine; Bandages; Betamethasone; Chloramphenicol; Down Syndrome; Female; Humans; Hydrocortisone; Keratoconus; Male; Prednisolone; Visual Acuity | 1971 |
Return of goblet cells after vitamin A therapy in xerosis of the conjunctiva.
Topics: Adult; Alcoholism; Atropine; Biopsy; Chloramphenicol; Conjunctiva; Corneal Ulcer; Gentamicins; Humans; Male; Polymyxins; Staphylococcal Infections; Streptococcal Infections; Visual Acuity; Vitamin A; Vitamin A Deficiency; Xerophthalmia | 1973 |
Paediatric pharmacology.
Topics: Age Factors; Aminobenzoates; Anesthesia; Animals; Atropine; Autonomic Nervous System; Bis-Trimethylammonium Compounds; Blood-Brain Barrier; Body Fluids; Child; Child, Preschool; Chloramphenicol; Humans; Infant; Infant, Newborn; Neostigmine; Pharmaceutical Preparations; Pharmacogenetics; Pharmacology; Poisoning; Preanesthetic Medication; Protein Binding; Synaptic Transmission; Tubocurarine | 1973 |
Dyskeratotic marginal keratoconjunctivitis in hereditary periodontopathy and hyperkeratosis.
Topics: Adult; Atropine; Biopsy; Child; Chloramphenicol; Conjunctiva; Cornea; Darier Disease; Epithelium; Follow-Up Studies; Gingival Hyperplasia; Granulation Tissue; Humans; Hyperplasia; Keratoconjunctivitis; Male; Natamycin; Ointments; Oxytetracycline; Polymyxins; Syndrome | 1974 |
Toad poisoning in small animals.
Topics: Animals; Anura; Atropine; Cat Diseases; Cats; Chloramphenicol; Dog Diseases; Dogs; Ethiopia; Female; Fever; Oxytetracycline; Pain; Paralysis; Poisoning; Prednisolone; Vomiting | 1973 |
Intracerebral antibiotics and androgenization of the neonatal female rat.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Atropine; Brain; Chloramphenicol; Cycloheximide; Dactinomycin; Female; Hypothalamus; Infertility, Female; Nerve Tissue Proteins; Ovulation; Procaine; Puromycin; Rats; Rifampin; Sexual Behavior, Animal; Streptomycin; Testosterone | 1972 |
[Eye damage from caterpillar hairs].
Topics: Absorption; Atropine; Chitin; Chloramphenicol; Eye Diseases; Eye Foreign Bodies; Eye Injuries; Humans; Insecta; Ketones; Larva; Ointments; Papilledema; Phenazines; Polysaccharides; Prednisone; Pyrazoles; Seasons | 1971 |
Drugs and children.
Topics: Aminophylline; Aspirin; Atropine; Cardiomyopathies; Cataract; Child, Preschool; Chloramphenicol; Chlorothiazide; Conjunctivitis; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Iatrogenic Disease; Infant; Infant, Newborn; Infant, Newborn, Diseases; Male; Ophthalmic Solutions; Pre-Eclampsia; Pregnancy; Purpura, Thrombocytopenic; Substance-Related Disorders; Suppositories | 1968 |
[The effect of externally used drugs on the corneal endothelium].
Topics: Anesthetics, Local; Animals; Atropine; Chloramphenicol; Cocaine; Cornea; Dexamethasone; Hydrocortisone; Parathion; Rabbits; Tetracycline | 1965 |
Intercalary staphyloma in a case of herpes zoster ophthalmicus.
Topics: Aged; Atropine; Chloramphenicol; Eye Diseases; Herpes Zoster Ophthalmicus; Humans; Intraocular Pressure; Male; Prednisone; Sclera; Tonometry, Ocular; Uveitis, Anterior; Vision Tests | 1967 |
Zoster ophthalmicus. Local treatment with cortisone.
Topics: Adolescent; Adult; Aged; Atropine; Chloramphenicol; Cortisone; Female; Herpes Zoster Ophthalmicus; Humans; Male; Middle Aged | 1967 |
[Effect on the sensitivity of the cornea to several drugs administered into the conjunctival sac].
Topics: Adolescent; Adult; Anesthetics, Local; Atropine; Benactyzine; Child; Chloramphenicol; Conjunctiva; Cornea; Cortisone; Humans; Middle Aged; Ophthalmic Solutions; Penicillins; Tropanes | 1969 |
Sympathetic keratitis presumably herpetic.
Topics: Atropine; Blindness; Chloramphenicol | 1970 |
Focal degeneration of the cornea with sequestration in a cat.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Atropine; Cat Diseases; Cats; Chloramphenicol; Corneal Ulcer; Electrocoagulation; Eye Diseases; Female; Ointments; Physostigmine; Prednisolone | 1966 |
Dissociation of rapid eye movement (REM) sleep features: possible implications for REM triggering mechanisms.
Topics: Animals; Atropine; Biomechanical Phenomena; Cats; Chloramphenicol; Electromyography; Reticular Formation; Sleep Deprivation; Sleep, REM; Thiamphenicol | 1983 |
FUNGUS CORNEAL ULCER.
Topics: Amphotericin B; Anti-Bacterial Agents; Atropine; Chloramphenicol; Cornea; Corneal Ulcer; Diabetes Mellitus; Eye Injuries; Fusarium; Glaucoma; Humans; Mycoses; Ointments; Ophthalmic Solutions; Ophthalmology; Penicillins; Streptomycin; Toxicology; Ulcer | 1963 |
REPARATIVE GIANT CELL GRANULOMA: REPORT OF CASE.
Topics: Atropine; Child; Chloramphenicol; Granuloma; Granuloma, Giant Cell; Humans; Mandible; Meperidine; Pathology; Radiography; Surgery, Oral | 1964 |
MALATHION POISONING SUCCESSFULLY TREATED WITH LARGE DOSES OF ATROPINE.
Topics: Anti-Bacterial Agents; Atropine; Chloramphenicol; Cholinesterases; Depression; Depressive Disorder; Escherichia coli Infections; Malathion; Metabolism; Neurologic Manifestations; Organophosphate Poisoning; Oximes; Penicillins; Pharmacology; Phosphorus; Poisons; Pralidoxime Compounds; Prednisone; Pyridines; Streptomycin; Suicide; Tetracycline; Toxicology | 1964 |
HERPES ZOSTER OPHTHALMICUS IN AN 8-YEAR-OLD CHILD.
Topics: Atropine; Chickenpox; Child; Chloramphenicol; Eye; Facial Dermatoses; Folic Acid; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Penicillin V; Penicillins; Vitamin B Complex | 1963 |
Eye ointment packaging and drug errors.
Topics: Atropine; Chloramphenicol; Drug Packaging; Eye Diseases; Female; Follow-Up Studies; Humans; Ireland; Medication Errors; Middle Aged; Ointments; Risk Assessment | 2004 |